Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine vs Fexofenadine in Histamine Induced Response
NCT01586091Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levocetirizine, fexofenadine in urticaria, allergic rhinitis (AR), pruritus, sponsored by Charité – Universitätsmedizin Berlin. Started Feb 2011; status: completed.
02
Drugs
levocetirizinefexofenadine
03
Conditions
urticariaallergic rhinitis (AR)pruritus
Beyond the preview
Go deeper on NCT01586091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01586091.